Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-25-000044
Filing Date
2025-05-09
Accepted
2025-05-09 06:59:55
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20250331.htm   iXBRL 10-Q 917885
2 EX-31.1 kprx-20250331xexx311.htm EX-31.1 7430
3 EX-31.2 kprx-20250331xexx312.htm EX-31.2 7426
4 EX-32.1 kprx-20250331xexx321.htm EX-32.1 3838
5 EX-32.2 kprx-20250331xexx322.htm EX-32.2 3823
11 KIORA LOGO kprx-20250331_g1.jpg GRAPHIC 348944
  Complete submission text file 0001372514-25-000044.txt   7473176

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20250331.xsd EX-101.SCH 45808
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20250331_cal.xml EX-101.CAL 71555
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20250331_def.xml EX-101.DEF 243205
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20250331_lab.xml EX-101.LAB 670063
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20250331_pre.xml EX-101.PRE 449398
74 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20250331_htm.xml XML 918973
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 25928305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)